Quest Diagnostics
DGX
#1095
Rank
HK$158.87 B
Marketcap
HK$1,421
Share price
-0.91%
Change (1 day)
15.54%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$68.66 Billion

According to Quest Diagnostics 's latest financial reports the company's total liabilities are HK$68.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Quest Diagnostics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$71.86 B21.01%
2023-12-31HK$59.38 B11.29%
2022-12-31HK$53.36 B-2.91%
2021-12-31HK$54.96 B-0.63%
2020-12-31HK$55.31 B0.31%
2019-12-31HK$55.13 B24.43%
2018-12-31HK$44.31 B3.73%
2017-12-31HK$42.72 B2.73%
2016-12-31HK$41.58 B3.6%
2015-12-31HK$40.14 B-6.37%
2014-12-31HK$42.87 B11.13%
2013-12-31HK$38.57 B-2.37%
2012-12-31HK$39.51 B-9.12%
2011-12-31HK$43.48 B24.9%
2010-12-31HK$34.81 B-1.37%
2009-12-31HK$35.29 B-4.82%
2008-12-31HK$37.08 B-9.26%
2007-12-31HK$40.86 B98.86%
2006-12-31HK$20.55 B4.22%
2005-12-31HK$19.71 B32.49%
2004-12-31HK$14.88 B0.7%
2003-12-31HK$14.77 B21.85%
2002-12-31HK$12.12 B-2.45%
2001-12-31HK$12.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
LabCorp
LH
HK$74.33 B 8.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
HK$24.81 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
HK$4.17 B-93.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
HK$0.15 B-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$22.60 B-67.08%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands